Literature DB >> 17611709

Nationwide survey on predictive genetic testing for late-onset, incurable neurological diseases in Japan.

Kunihiro Yoshida1,2, Takahito Wada3,4, Akihiro Sakurai3,4, Keiko Wakui3,4, Shu-Ichi Ikeda5, Yoshimitsu Fukushima3,4.   

Abstract

A nationwide survey was conducted for predictive genetic testing for late-onset, incurable neurological diseases. A questionnaire was sent to 125 university hospitals and national hospitals, and was returned by 69% of them. Of the 86 responding hospitals, 63 had genetic counseling clinics and answered the questions concerning predictive testing. Of these, 46 had experienced clients with an interest in or a request for predictive testing during the period from April 2004 to March 2006. A total of 322 clients were accumulated, the majority of which were interested in myotonic dystrophy (n = 150), followed by spinocerebellar ataxia (n = 86), spinal and bulbar muscular atrophy (n = 40) and Huntington's disease (n = 31). Most such clients were counseled by medical doctors, who had the "Japanese Board of Medical Genetics, Clinical Geneticist" certification, but others, including neurologists, nurses, clinical psychologists or genetic counselors also contributed, albeit to a lesser extent, to genetic counseling in Japan. Many respondents felt that a multidisciplinary approach by a counseling team consisting of a clinical geneticist, a neurologist, a genetic nurse, a clinical psychologist and a genetic counselor had not yet been established. There will be a great need for educated and trained non-medical doctor staff not only to improve the quality of genetic counseling and psychological support for such clients, but also to conduct the psychosocial research on Japanese clients requesting predictive genetic testing.

Entities:  

Mesh:

Year:  2007        PMID: 17611709     DOI: 10.1007/s10038-007-0170-1

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  10 in total

1.  [Analysis of 14 individuals who requested predictive genetic testing for hereditary neuromuscular diseases].

Authors:  Kunihiro Yoshida; Mariko Tamai; Takeo Kubota; Hiroshi Kawame; Naoji Amano; Shu-ichi Ikeda; Yoshimitsu Fukushima
Journal:  Rinsho Shinkeigaku       Date:  2002-02

2.  Predictive testing for Huntington's disease: ten years' experience in two Italian centres.

Authors:  P Mandich; G Jacopini; E Di Maria; G Sabbadini; G Abbruzzese; F Chimirri; E Bellone; A Novelletto; F Ajmar; M Frontali
Journal:  Ital J Neurol Sci       Date:  1998-04

3.  Ethical dilemmas in testing for late onset conditions: reactions to testing and perceived impact on other family members.

Authors:  Elizabeth Chapman
Journal:  J Genet Couns       Date:  2002-10       Impact factor: 2.537

4.  Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea.

Authors: 
Journal:  Neurology       Date:  1994-08       Impact factor: 9.910

5.  High suicidal ideation in persons testing for Huntington's disease.

Authors:  T B Robins Wahlin; L Bäckman; A Lundin; A Haegermark; B Winblad; M Anvret
Journal:  Acta Neurol Scand       Date:  2000-09       Impact factor: 3.209

Review 6.  Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals.

Authors:  G Evers-Kiebooms; M Decruyenaere
Journal:  Patient Educ Couns       Date:  1998-09

7.  Predictive genetic test decisions for Huntington's disease: context, appraisal and new moral imperatives.

Authors:  Sandra D Taylor
Journal:  Soc Sci Med       Date:  2004-01       Impact factor: 4.634

8.  Predictive testing for Huntington's disease: protocol of the UK Huntington's Prediction Consortium.

Authors:  D Craufurd; A Tyler
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

9.  Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants.

Authors:  M Decruyenaere; G Evers-Kiebooms; A Boogaerts; J J Cassiman; T Cloostermans; K Demyttenaere; R Dom; J P Fryns; H Van den Berghe
Journal:  Genet Couns       Date:  1995

10.  Presymptomatic testing for huntington diseases: Recommendations for counseling.

Authors:  K A Quaid
Journal:  J Genet Couns       Date:  1992-12       Impact factor: 2.537

  10 in total
  1 in total

1.  Investigating the role of genetic counseling in neuromuscular disease considering life events.

Authors:  Yuka Shibata; Ichiro Yabe; Masaaki Matsushima; Naoki Hashimoto; Takahiro Yamada; Hidenao Sasaki
Journal:  J Hum Genet       Date:  2019-03-13       Impact factor: 3.172

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.